Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Adamantane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D known ✓ | O15399 | 1/20 | 0.33 |
| ▸ | GRIN3B known ✓ | O60391 | 1/20 | 0.33 |
| ▸ | GRIN1 known ✓ | Q05586 | 1/20 | 0.33 |
| ▸ | GRIN2A known ✓ | Q12879 | 1/20 | 0.33 |
| ▸ | GRIN2B known ✓ | Q13224 | 1/20 | 0.33 |
| ▸ | GRIN2C known ✓ | Q14957 | 1/20 | 0.33 |
| ▸ | GRIN3A known ✓ | Q8TCU5 | 1/20 | 0.33 |
| ▸ | SIGMAR1 known ✓ | Q99720 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.33 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | STAT6 | P42226 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adamantane SCHEMBL28257325 | 1.00 | CYP2C9 (0.43) | CYP2C9LMNAPOLBTHRBBLM | |
| Adamantane SCHEMBL30536640 | 1.00 | CYP2C9 (0.43) | CYP2C9LMNAPOLBTHRBBLM | |
| Adamantane SCHEMBL18065809 | 0.94 | CYP2C9 (0.40) | CYP2C9LMNAPOLBTHRBBLM | |
| Adamantane SCHEMBL28551331 | 0.94 | CYP2C9 (0.40) | CYP2C9LMNAPOLBTHRBBLM | |
| Hydrochloric Acid SCHEMBL30759508 | 0.93 | — | — | |
| Adamantane SCHEMBL29707714 | 0.93 | CYP2C9 (0.46) | CYP2C9LMNAPOLBTHRBBLM | |
| Adamantane SCHEMBL1527414 | 0.93 | CYP2C9 (0.46) | CYP2C9LMNAPOLBTHRBBLM | |
| Adamantane SCHEMBL12761 | 0.93 | CYP2C9 (0.46) | CYP2C9LMNAPOLBTHRBBLM | |
| Adamantane SCHEMBL9016497 | 0.93 | CYP2C9 (0.46) | CYP2C9LMNAPOLBTHRBBLM | |
| Adamantane SCHEMBL7154373 | 0.88 | CYP2C9 (0.38) | CYP2C9LMNAPOLBTHRBBLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115501350-A | Fluorescent supramolecular nano-carrier and preparation method and application thereof | 浙江大学 | 2022-12-23 | — | — | CN | claimed |
| CN-110487919-A | A method of detection amantadine hydrochloride soft capsule cleans residual quantity | HUMANWELL PURACAP PHARMACEUTICALS WUHAN CO LTD | 2019-11-22 | — | — | CN | claimed |
| CN-110412141-A | A method of measurement amantadine hydrochloride soft capsule residual solvent isopropanol | HUMANWELL PURACAP PHARMACEUTICALS WUHAN CO LTD | 2019-11-05 | — | — | CN | claimed |
| CN-106332881-B | Dibromo malonamide composition and its purposes as biocide | 陶氏环球技术有限责任公司 | 2019-02-26 | — | — | CN | claimed |
| CN-106832334-B | A kind of organic-inorganic hybrid nanometer particle and preparation method thereof based on branched polyethylene imine and hexahedron oligomeric silsesquioxane | 中南大学 | 2018-10-26 | — | — | CN | claimed |
| CN-108530313-A | A kind of high price iodine oxidation agent and preparation method thereof | 石家庄学院 | 2018-09-14 | — | — | CN | claimed |
| CN-106832334-A | A kind of organic-inorganic hybrid nanometer particle based on branched polyethylene imine and hexahedron oligomeric silsesquioxane and preparation method thereof | 中南大学 | 2017-06-13 | — | — | CN | claimed |
| CN-106332881-A | COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES | 陶氏环球技术有限责任公司 | 2017-01-18 | — | — | CN | claimed |
| CN-104886051-A | Compositions of dibromomalonamide and their use as biocides | DOW GLOBAL TECHNOLOGIES LLC | 2015-09-09 | — | — | CN | claimed |
| CN-102548403-A | Dibromomalonamide compositions and their use as biocides | DOW GLOBAL TECHNOLOGIES LLC | 2012-07-04 | — | — | CN | claimed |
| EP-2193369-A1 | A HIGH THROUGHPUT TEST METHOD FOR EVALUATION OF BIOCIDES AGAINST ANAEROBIC MICROORGANISMS | Dow Global Technologies Inc. (US) | 2010-06-09 | — | — | EP | claimed |
| WO-2009039004-A1 | A HIGH THROUGHPUT TEST METHOD FOR EVALUATION OF BIOCIDES AGAINST ANAEROBIC MICROORGANISMS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2009-03-26 | — | — | WO | claimed |
| JP-55016039-A | — | — | None | — | — | JP | disclosed |
| CN-120051604-A | Liquid impregnated surface modified material | 欧米亚国际集团 | 2025-05-27 | — | — | CN | disclosed |
| CN-116322328-B | Pesticide composition comprising elemental sulphur and choline salts of pelargonic acid | 希特逊库玛·阿尼凯特·多希 | 2025-05-06 | — | — | CN | disclosed |
| CN-118791439-B | Preparation method of modified betaine and antibacterial cellulose ether containing modified betaine | 美信佳中维药业股份有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-1689692-A | Surfactant | SAN NOPCO KK (JP) | 2005-11-02 | — | — | CN | disclosed |
| US-6080244-A | CLEANING HYDROPHOBIC SOILS FROM A METAL SURFACE BY SEQUENTIALLY CLEANING WITH FIRST SOLUTION CONTAINING LOW-FOAMING NONIONIC SURFACTANT THEN WITH SECOND SOLUTION CONTAINING LIPASE OR LIPASE/CATALASE MIXTURE | CALGON CORPORATION (US) | 2000-06-27 | — | — | US | disclosed |
| EP-0007572-A1 | Pharmaceutical mixtures containing an amantadine compound | CIBA-GEIGY AG (CH) | 1980-02-06 | — | — | EP | disclosed |
| JP-S5516039-A | RECORDING MEDIUM LIQUID | CANON INC | 1980-02-04 | — | — | JP | disclosed |